Search

Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 949.90 3.40  | 0.36% 26.97% 24.42 26,839.58
NSE Price: Feb 20, 11:24 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Feb 20, 11:24 949.90 3.40 0.36% 946.00 946.50 90,802 938.95 - 954.70
BSE Feb 20, 11:29 951.20 4.30 0.45% 947.00 946.90 6,531 940.00 - 954.10
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 609,360 P/B: 5.86 NSE Code: GLENMARK
52-Week Range: R 715.45 - 994.00 Dividend Yield: 0.21% BSE Code: 532296
TTM EPS: R 38.94 Book Value: R 162.17 Face Value: R 1
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • S&P BSE 100


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. 6.53 7.03 7.08 31.08 20.72 25.78 11.83
S&P BSE Sensex 6.92 4.53 8.54 21.76 11.62 9.24 7.08
S&P BSE Healthcare 4.07 2.01 2.09 0.84 14.45 19.15 14.93
Company's return has been calculated on basis of NSE's price.
As on Feb 17, 2017
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 15.55 15.82 21.22
Net Profit 243.67 4.64 9.47
EPS 230.41 3.69 8.76
Book Value 64.77 2.02 7.52
Average
Operating Margin 18.83 18.55 18.90
Net Margin 9.30 7.20 9.14
Return on Networth 29.75 19.18 20.56
Return on Investment 19.04 15.49 15.72
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 13.98 42.55 11.12
Operating Profit 74.43 109.16 148.02
Net Profit 113.39 143.26 178.53
EPS 113.35 143.15 178.17
TTM
Revenue 9.20 26.33 17.94
Operating Profit 25.61 40.18 37.05
Net Profit 34.36 81.40 43.37
EPS 34.33 81.25 43.32
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 26,839.58 8,983.42 1,098.76 12.10 29.75 5.86 24.42
Lupin 65,861.88 17,393.95 2,986.60 16.94 23.05 5.02 22.07
Sun Pharmaceutical Inds. 163,870.15 32,054.93 8,453.68 26.05 20.47 4.26 21.98
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Feb 08, 2017 Oppenheimer Fund Inc(FII)  Buy Market 74,647 957.70 714.89
Nov 09, 2016 Robin Pinto  Buy Market 500 899.50 4.50
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 12,200 707.70 86.34
Sep 23, 2014 Blanche Elizabeth Saldanha  Buy Market 20,000 707.70 141.54
Sep 11, 2014 Blanche Elizabeth Saldanha  Buy Market 17,980 765.30 137.60
Fund Houses invested in the stock
Fund Dec-16 Sep-16 Jun-16 Mar-16 Dec-15
Birla Sun Life Mutual Fund 0.977 - - 0.178 0.317
Tata Mutual Fund 0.921 0.861 0.697 0.733 -
Reliance Mutual Fund 0.314 0.043 0.007 0.017 0.033
Sundaram Mutual Fund 0.298 0.279 0.256 0.256 0.256
SBI Mutual Fund 0.259 0.192 0.229 0.221 0.195
Kotak Mahindra Mutual Fund 0.117 0.063 0.098 0.040 0.101
HDFC Mutual Fund 0.113 0.139 0.117 0.101 0.114
HSBC Mutual Fund 0.097 0.087 0.087 0.119 0.085
IDFC Mutual Fund 0.091 0.031 0.049 0.061 0.056
BNP Paribas Mutual Fund 0.072 - - - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: webmaster@glenmarkpharma.com

Website: www.glenmarkpharma.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: einward.ris@karvy.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: einward.ris@karvy.com

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
4.60
Piotroski F-Score
7
Modified C-Score
2
5-Years Price to Earnings
24.32
5-Years Price to Book
5.84
Earnings Yield
EBIT / Enterprise value
5.82%
PEG
Price / Earnings to growth ratio
1.17
Related Stocks
  Current Price   Chng %
Aurobindo Pharma R672.65 +1.20%
Biocon R1,118.50 +1.19%
Cadila Healthcare R442.75 -1.62%
Cipla R590.35 -0.49%
Dr. Reddy's Lab R2,901.30 -0.39%
Glaxosmithkline Pharma R2,696.30 +0.15%
Lupin R1,460.00 +0.09%
Piramal Enterprises R1,879.85 -0.19%
Sun Pharmaceutical Inds. R683.05 +1.12%
Torrent Pharmaceuticals R1,294.05 +2.65%
As on Feb 20, 11:24